Ginkgo Bioworks inks AI partnership with Google Cloud
JHVEPhoto/iStock Editorial via Getty Images

Shares of Ginkgo Bioworks (NYSE:DNA) added ~10% pre-market Tuesday after the cell platform company and Google Cloud, a unit of tech giant Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL), announced a five-year cloud and AI partnership.
The deal focused on cloud and AI technology will help companies build large language models (LLMs) running on Google Cloud's Vertex AI platform in genomics, protein function, and synthetic biology.

Per the terms, Ginkgo will pick Google Cloud as its primary cloud services provider, and Google Cloud will fund the company's efforts to reach certain milestones over the next three years.
Gingko (DNA) said that following the partnership, its customers will be able to accelerate innovation and discovery in multiple fields across drug discovery, agriculture, industrial manufacturing, and biosecurity.



More on Google, Gingko, etc.

Google: Undervalued And Positioned To Gain From Economic Strength
Google: Strong Company At A Reasonable Price
Ginkgo Bioworks: Lack Of Progress Is A Concern
Google: Duet AI Google Workspace's GenAI Solution Vs. Microsoft M365 CoPilot
Meta, Google could see new digital services tax in New Zealand in 2025 - report
Meta, Google, others said to meet with Sen. Schumer on AI next month
Google's AI 'counteroffensive taking shape,' Baird says
ChatGPT can provide inaccurate recommendations for cancer treatment
Google, Amazon among 13 potential AI catalysts for rest of 2023: Morgan Stanley
YouTube sets up Music AI incubator, teaming with Universal Music